Literature DB >> 10097146

Loss of transformed phenotype in cancer cells by overexpression of the uteroglobin gene.

Z Zhang1, G C Kundu, D Panda, A K Mandal, G Mantile-Selvaggi, A Peri, C J Yuan, A B Mukherjee.   

Abstract

Uteroglobin (UG) is a multifunctional, secreted protein that has receptor-mediated functions. The human UG (hUG) gene is mapped to chromosome 11q12.2-13.1, a region frequently rearranged or deleted in many cancers. Although high levels of hUG expression are characteristic of the mucosal epithelia of many organs, hUG expression is either drastically reduced or totally absent in adenocarcinomas and in viral-transformed epithelial cells derived from the same organs. In agreement with these findings, in an ongoing study to evaluate the effects of aging on UG-knockout mice, 16/16 animals developed malignant tumors, whereas the wild-type littermates (n = 25) remained apparently healthy even after 11/2 years. In the present investigation, we sought to determine the effects of induced-expression of hUG in human cancer cells by transfecting several cell lines derived from adenocarcinomas of various organs with an hUG-cDNA construct. We demonstrate that induced hUG expression reverses at least two of the most important characteristics of the transformed phenotype (i.e., anchorage-independent growth on soft agar and extracellular matrix invasion) of only those cancer cells that also express the hUG receptor. Similarly, treatment of the nontransfected, receptor-positive adenocarcinoma cells with purified recombinant hUG yielded identical results. Taken together, these data define receptor-mediated, autocrine and paracrine pathways through which hUG reverses the transformed phenotype of cancer cells and consequently, may have tumor suppressor-like effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10097146      PMCID: PMC22403          DOI: 10.1073/pnas.96.7.3963

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Binding of steroids to uteroglobin.

Authors:  M Beato
Journal:  J Steroid Biochem       Date:  1976-05       Impact factor: 4.292

2.  Inhibition of phagocyte chemotaxis by uteroglobin, an inhibitor of blastocyst rejection.

Authors:  G Vasanthakumar; R Manjunath; A B Mukherjee; H Warabi; E Schiffmann
Journal:  Biochem Pharmacol       Date:  1988-02-01       Impact factor: 5.858

3.  Amino-acid and cDNA nucleotide sequences of human Clara cell 10 kDa protein.

Authors:  G Singh; S L Katyal; W E Brown; S Phillips; A L Kennedy; J Anthony; N Squeglia
Journal:  Biochim Biophys Acta       Date:  1988-09-07

Review 4.  Modulation of cellular response to antigens by uteroglobin and transglutaminase.

Authors:  A B Mukherjee; E Cordella-Miele; T Kikukawa; L Miele
Journal:  Adv Exp Med Biol       Date:  1988       Impact factor: 2.622

5.  "Blastokinin": inducer and regulator of blastocyst development in the rabbit uterus.

Authors:  R S Krishnan; J C Daniel
Journal:  Science       Date:  1967-10-27       Impact factor: 47.728

6.  The binding of methylsulfonyl-polychloro-biphenyls to uteroglobin.

Authors:  M Gillner; J Lund; C Cambillau; M Alexandersson; U Hurtig; A Bergman; E Klasson-Wehler; J A Gustafsson
Journal:  J Steroid Biochem       Date:  1988-07       Impact factor: 4.292

Review 7.  Uteroglobin: physiological role in normal glomerular function uncovered by targeted disruption of the uteroglobin gene in mice.

Authors:  A B Mukherjee; G C Kundu; A K Mandal; N Pattabiraman; C J Yuan; Z Zhang
Journal:  Am J Kidney Dis       Date:  1998-12       Impact factor: 8.860

8.  T24 human bladder carcinoma cells with activated Ha-ras protooncogene: nontumorigenic cells susceptible to malignant transformation with carcinogen.

Authors:  D R Senger; C A Perruzzi; I U Ali
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Inhibition of thrombin-induced platelet aggregation by uteroglobin.

Authors:  R Manjunath; S W Levin; K K Kumaroo; J D Butler; J A Donlon; M Horne; R Fujita; U K Schumacher; A B Mukherjee
Journal:  Biochem Pharmacol       Date:  1987-03-01       Impact factor: 5.858

10.  Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells.

Authors:  P J Saxon; E S Srivatsan; E J Stanbridge
Journal:  EMBO J       Date:  1986-12-20       Impact factor: 11.598

View more
  6 in total

Review 1.  The effects of an autocrine loop mediated by platelet-activating factor (PAF) in HEC-1A cells are reverted by uteroglobin.

Authors:  Alessandro Peri; Lorella Bonaccorsi; Federica Cioppi; Monica Muratori; Michaela Luconi; Simone Granchi; Mario Maggi; Elisabetta Baldi
Journal:  Hum Cell       Date:  2003-09       Impact factor: 4.174

2.  Uteroglobin promoter-targeted c-MYC expression in transgenic mice cause hyperplasia of Clara cells and malignant transformation of T-lymphoblasts and tubular epithelial cells.

Authors:  A Geick; P Redecker; A Ehrhardt; R Klocke; D Paul; R Halter
Journal:  Transgenic Res       Date:  2001-12       Impact factor: 2.788

3.  Lack of an endogenous anti-inflammatory protein in mice enhances colonization of B16F10 melanoma cells in the lungs.

Authors:  Arjun Saha; Yi-Ching Lee; Zhongjian Zhang; Goutam Chandra; Shao-Bo Su; Anil B Mukherjee
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

4.  In vivo Cre/loxP mediated recombination in mouse Clara cells.

Authors:  Guillaume Bertin; Chantal Poujeol; Isabelle Rubera; Philippe Poujeol; Michel Tauc
Journal:  Transgenic Res       Date:  2005-10       Impact factor: 2.788

5.  Serum concentrations of club cell secretory protein (Clara) and cancer mortality in adults: a population-based, prospective cohort study.

Authors:  Stefano Guerra; Monica M Vasquez; Amber Spangenberg; Marilyn Halonen; Fernando D Martinez
Journal:  Lancet Respir Med       Date:  2013-11-15       Impact factor: 30.700

6.  Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice.

Authors:  Wei Liu; Jing Wan; Jian-Zhong Han; Chen Li; Dan-Dan Feng; Shao-Jie Yue; Yan-Hong Huang; Yi Chen; Qing-Mei Cheng; Yang Li; Zi-Qiang Luo
Journal:  Respir Res       Date:  2013-10-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.